Full name
CENTRUM DIAGNOSTYCZNE "ASPER" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
CENTRUM DIAGNOSTYCZNE "ASPER" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. BOHATERÓW WARSZAWY 11, 43-100 TYCHY
TAX ID6462442675
Rate company:
CENTRUM DIAGNOSTYCZNE "ASPER" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID6462442675
KRS0000137182
Share capital50,000.00 zł
address
UL. BOHATERÓW WARSZAWY 11, 43-100 TYCHY
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
6462442675
REGON
276684556
KRS
0000137182
Legal form
limited liability company
Register Address
UL. BOHATERÓW WARSZAWY 11, 43-100 TYCHY
Date of registration in KRS
2002-10-29
Date of commencement of economic activity
2002-10-29
Act signature
RDF/706267/25/959
Pkd codes
86.22.Z - Specialist medical practice
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
68.20.Z - Rental and management of own or leased real estate
82.19.Z - Office administrative support activities and other business support services
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.21.Z - General medical practice
86.90.C - Healthcare
86.90.E - Healthcare
Payer VAT status
exempted
Vat list bank account(s)
PL86 1050 1399 1000 0022 9045 0903 
PL65 1050 1399 1000 0022 2545 8856 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets  | 1,3 | 1 | 1,4 | 40 |
Gross profit (loss) | 1,1 | 1,2 | 1,5 | 27,6 |
EBITDA | 1,1 | 1,2 | 1,5 | 27,4 |
Net profit (loss) | 1 | 1,1 | 1,4 | 27,2 |
Cash | 0,9 | 0,6 | 1 | 66,1 |
Net income from sale | 3,3 | 3,6 | 3,8 | 4,6 |
Liabilities and provisions for liabilities | 0,2 | 0,2 | 0,1 | -49,7 |
Short time liabilities | 0,1 | 0,2 | 0,1 | -46,1 |
Working assets | 1,2 | 0,9 | 1,3 | 45,8 |
Equity capital | 1,1 | 0,8 | 1,3 | 65,8 |
Operating profit (EBIT) | 1,1 | 1,2 | 1,5 | 27,5 |
Depreciation | 0,1 | 0 | 0 | -0,7 |
% | % | % | p.p. | |
Profitability of capital | 91,1 | 139,1 | 106,7 | -32,4 |
Equity capital to total assets | 85,8 | 77,6 | 91,9 | 14,3 |
Gross profit margin | 32,7 | 33,4 | 40,8 | 7,4 |
EBITDA Margin | 34,5 | 33,4 | 40,7 | 7,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 13 | 20 | 10 | -10 |
Financial statements
01-01-2024 - 31-12-2024
Annual financial report
Download xml01-01-2024 - 31-12-2024
Annual financial report
Download pdf01-01-2024 - 31-12-2024
Activity report
Download pdf01-01-2024 - 31-12-2024
Resolution or decision approving the annual financial statements
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.